Addressing barriers to and strategies for herpes zoster vaccination in immunocompromised patients in Türkiye: an expert consensus.

IF 4.8 3区医学 Q1 IMMUNOLOGY

Expert Review of Vaccines Pub Date : 2025-12-01 Epub Date: 2025-09-03 DOI:10.1080/14760584.2025.2550979

Cihan Yeşiloğlu, Bülent Altun, Onur Keskin, Ömer Dizdar, Sedat Kiraz, Serhat Ünal, Yahya Büyükaşık, Selim Badur

{"title":"Addressing barriers to and strategies for herpes zoster vaccination in immunocompromised patients in Türkiye: an expert consensus.","authors":"Cihan Yeşiloğlu, Bülent Altun, Onur Keskin, Ömer Dizdar, Sedat Kiraz, Serhat Ünal, Yahya Büyükaşık, Selim Badur","doi":"10.1080/14760584.2025.2550979","DOIUrl":null,"url":null,"abstract":"Objectives: Immunocompromised (IC) patients are at increased risk of herpes zoster (HZ; i.e. shingles) and subsequent complications which can significantly impact quality of life. While current evidence indicates a strong disease presence of HZ in Türkiye, literature on the management of HZ in this population is lacking.Methods: We conducted a survey with 6 disease experts from various medical specialties in Türkiye to understand their opinions on the burden of HZ and the challenges faced by IC patients, in order to establish a comprehensive and evidence-based expert consensus.Results: Experts agreed that the burden of HZ is significant among IC patients in Türkiye. However, they identified a need for increased local epidemiological data to better understand the health impact of HZ in Türkiye. Improved dissemination of information regarding HZ to physicians was also highlighted to increase awareness of HZ.Conclusions: Strategies to enhance current practices and increase vaccine coverage should include incorporation of HZ vaccination into official guidelines and recommendations, with full or partial reimbursement for HZ vaccination in IC patients. Setting up official or society-initiated online platforms could also support ongoing collaboration and provide continuously updated guidelines reflecting the latest advances in HZ vaccination and disease management.","PeriodicalId":12326,"journal":{"name":"Expert Review of Vaccines","volume":" ","pages":"860-869"},"PeriodicalIF":4.8000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14760584.2025.2550979","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: Immunocompromised (IC) patients are at increased risk of herpes zoster (HZ; i.e. shingles) and subsequent complications which can significantly impact quality of life. While current evidence indicates a strong disease presence of HZ in Türkiye, literature on the management of HZ in this population is lacking.

Methods: We conducted a survey with 6 disease experts from various medical specialties in Türkiye to understand their opinions on the burden of HZ and the challenges faced by IC patients, in order to establish a comprehensive and evidence-based expert consensus.

Results: Experts agreed that the burden of HZ is significant among IC patients in Türkiye. However, they identified a need for increased local epidemiological data to better understand the health impact of HZ in Türkiye. Improved dissemination of information regarding HZ to physicians was also highlighted to increase awareness of HZ.

Conclusions: Strategies to enhance current practices and increase vaccine coverage should include incorporation of HZ vaccination into official guidelines and recommendations, with full or partial reimbursement for HZ vaccination in IC patients. Setting up official or society-initiated online platforms could also support ongoing collaboration and provide continuously updated guidelines reflecting the latest advances in HZ vaccination and disease management.

查看原文本刊更多论文

解决 kiye免疫功能低下患者带状疱疹疫苗接种的障碍和策略：专家共识。

目的：免疫功能低下（IC）患者患带状疱疹（HZ；即带状疱疹）和随后并发症的风险增加，这可能显著影响生活质量。虽然目前的证据表明在基耶族中有很强的HZ疾病存在，但缺乏关于该人群中HZ管理的文献。方法：通过对基耶省各医学专业的6名疾病专家进行调查，了解他们对HZ负担和IC患者面临的挑战的看法，以建立全面、循证的专家共识。结果：专家一致认为，在日本，IC患者中HZ的负担是显著的。然而，他们发现有必要增加当地流行病学数据，以便更好地了解基耶省HZ对健康的影响。还强调了改善向医生传播有关HZ的信息，以提高对HZ的认识。结论：加强当前实践和增加疫苗覆盖率的策略应包括将HZ疫苗接种纳入官方指南和建议，并对IC患者的HZ疫苗接种进行全额或部分报销。建立官方或社会发起的在线平台也可以支持正在进行的合作，并提供不断更新的指南，反映HZ疫苗接种和疾病管理的最新进展。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Review of Vaccines 医学-免疫学

CiteScore

9.10

自引率

3.20%

发文量

136

审稿时长

4-8 weeks

期刊介绍： Expert Review of Vaccines (ISSN 1476-0584) provides expert commentary on the development, application, and clinical effectiveness of new vaccines. Coverage includes vaccine technology, vaccine adjuvants, prophylactic vaccines, therapeutic vaccines, AIDS vaccines and vaccines for defence against bioterrorism. All articles are subject to rigorous peer-review. The vaccine field has been transformed by recent technological advances, but there remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines facilitates decision making to drive forward this exciting field.